Cargando…
Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial
BACKGROUND: Neonatal hypoglycemia is common and can cause brain injury. Buccal dextrose gel is effective for treatment of neonatal hypoglycemia, and when used for prevention may reduce the incidence of hypoglycemia in babies at risk, but its clinical utility remains uncertain. METHODS AND FINDINGS:...
Autores principales: | Harding, Jane E., Hegarty, Joanne E., Crowther, Caroline A., Edlin, Richard P., Gamble, Gregory D., Alsweiler, Jane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842885/ https://www.ncbi.nlm.nih.gov/pubmed/33507929 http://dx.doi.org/10.1371/journal.pmed.1003411 |
Ejemplares similares
-
Randomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocol
por: Harding, Jane E, et al.
Publicado: (2015) -
Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study)
por: Hegarty, Joanne Elizabeth, et al.
Publicado: (2016) -
Neurocognitive Outcomes at Age 2 Years After Neonatal Hypoglycemia in a Cohort of Participants From the hPOD Randomized Trial
por: Edwards, Taygen, et al.
Publicado: (2022) -
Oral Dextrose Gel Reduces the Need for Intravenous Dextrose Therapy in Neonatal Hypoglycemia
por: Rawat, Munmun, et al.
Publicado: (2016) -
Dextrose Gel is Superior to Feeding Alone in Neonatal Hypoglycemia
por: Mosalli, Rafat
Publicado: (2014)